Skip to main content
Smart Investors Daily
DR

OTC · DRMTY

Dr. Martens plc

Consumer Cyclical · Apparel - Footwear & Accessories

$2.34

Up+$0.00 (+0.00%)

Updated Aug 17, 2026, 4:15 AM

SID Score

3.7/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
944.92M
P/E ratio
166.91
Dividend yield
2.88%
52-week range
— – —
Volume
523
Avg. volume
938

Price performance

DRMTY price history

1M range · 0 trading sessions · Daily adjusted prices

DRMTY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest DRMTY news

The latest Smart Investors Daily articles mentioning DRMTY.

DRMTY research

Overview

Company profile and research snapshot.

Company profile

DR MARTENS PLC U/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
DRMTY recent ratings
DateFirmRatingTarget
Jun 2, 2026RBC Capital MarketsSector Perform
May 19, 2026Berenberg BankBuy
May 6, 2026Berenberg BankBuy
Feb 3, 2026RBC Capital MarketsSector Perform
Jan 27, 2026Berenberg BankBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 13, 2026

Rezolve Ai Guides to $350 Million 2026 Revenue and $500 Million ARR Exit Run Rate

Company Signals Nearly 10× Growth for 2026 as Agentic Commerce Becomes Core Enterprise InfrastructureNEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a leader in Agentic Commerce and AI-powered customer engagement, today issued updated revenue guidance for 2025 and 2026, which are anticipated to materially exceed market expectations as enterprise adoption accelerates across its platform. For full-year 2025, Rezolve now expects to deliver at least $40 million in revenue, exc

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.